RB

Rituraj Butta

Active Director Director DIN 00652247
DIN 00652247 First appointment Dec 2001 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2001
Shareholding value •••• Premium profile

About Rituraj Butta

Data last updated:

Rituraj Butta is a Director at Medstocks Private Limited (since 2001). The company operates in Healthcare. Medstocks Private Limited reported revenue of ₹19.40 Cr (FY 2025).

DIN 00652247
Primary Designation Director
Industry Healthcare
First Appointment 05 Dec 2001
Oldest Company Age 40 yrs
Largest company Medstocks Private Limited · ₹19.40 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medstocks Private Limited U46497WB1986PTC039992
Director05 Dec 20011986₹19.40 Cr (FY 2025)Active

Board colleagues of Rituraj Butta

NameDINCompanyDesignation
Ashok Butta00652308Medstocks Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medstocks Private Limited
Premium access

Shareholding and investment profile for Rituraj Butta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rituraj Butta

Rituraj Butta currently holds 1 directorship: Medstocks Private Limited (Director, since 05 Dec 2001, revenue ₹19.40 Cr (FY 2025)).

Rituraj Butta was first appointed on 05 Dec 2001 as Director at Medstocks Private Limited.

The current boards of Rituraj Butta's companies include Ashok Butta (Medstocks Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available